Literature DB >> 8549343

Sparfloxacin secretion across Caco-2 cells involves a multidrug resistance-like mechanism.

E Cormet1, A M Barlier, J F Huneau, E Rubinstein, C Carbon, R Farinotti, D Tomé.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8549343     DOI： 10.2165/00003495-199500492-00080

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  10 in total

Review 1.  Pharmacology of drugs that alter multidrug resistance in cancer.

Authors:  J M Ford; W N Hait
Journal:  Pharmacol Rev       Date:  1990-09       Impact factor: 25.468

2.  Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability.

Authors:  I J Hidalgo; T J Raub; R T Borchardt
Journal:  Gastroenterology       Date:  1989-03       Impact factor: 22.682

3.  The intestinal elimination of ciprofloxacin in the rat.

Authors:  E Rubinstein; L St Julien; J Ramon; S Dautrey; R Farinotti; J F Huneau; C Carbon
Journal:  J Infect Dis       Date:  1994-01       Impact factor: 5.226

4.  Evidence for a polarized efflux system in CACO-2 cells capable of modulating cyclosporin A transport.

Authors:  P F Augustijns; T P Bradshaw; L S Gan; R W Hendren; D R Thakker
Journal:  Biochem Biophys Res Commun       Date:  1993-12-15       Impact factor: 3.575

5.  Transport of celiprolol across human intestinal epithelial (Caco-2) cells: mediation of secretion by multiple transporters including P-glycoprotein.

Authors:  J Karlsson; S M Kuo; J Ziemniak; P Artursson
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

6.  Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. Kinetics of vinblastine secretion and interaction with modulators.

Authors:  J Hunter; M A Jepson; T Tsuruo; N L Simmons; B H Hirst
Journal:  J Biol Chem       Date:  1993-07-15       Impact factor: 5.157

7.  Intestinal elimination of sparfloxacin, fleroxacin, and ciprofloxacin in rats.

Authors:  E Rubinstein; S Dautrey; R Farinoti; L St Julien; J Ramon; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

8.  Active secretion of the fluoroquinolone ciprofloxacin by human intestinal epithelial Caco-2 cell layers.

Authors:  N M Griffiths; B H Hirst; N L Simmons
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

9.  The function of Gp170, the multidrug-resistance gene product, in the brush border of rat intestinal mucosa.

Authors:  S Hsing; Z Gatmaitan; I M Arias
Journal:  Gastroenterology       Date:  1992-03       Impact factor: 22.682

10.  Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues.

Authors:  C Cordon-Cardo; J P O'Brien; J Boccia; D Casals; J R Bertino; M R Melamed
Journal:  J Histochem Cytochem       Date:  1990-09       Impact factor: 2.479
  10 in total
  2 in total

1.  Active intestinal elimination of ciprofloxacin in rats: modulation by different substrates.

Authors:  S Dautrey; K Felice; A Petiet; B Lacour; C Carbon; R Farinotti
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

Review 2.  Sparfloxacin. A review of its antibacterial activity, pharmacokinetic properties, clinical efficacy and tolerability in lower respiratory tract infections.

Authors:  K L Goa; H M Bryson; A Markham
Journal:  Drugs       Date:  1997-04       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.